Keymed Biosciences Inc. (HKG:2162)
72.95
-2.30 (-3.06%)
Jul 30, 2026, 4:08 PM HKT
Keymed Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $138.91 | Buy | Maintains | $138.91 | +90.42% | Jul 10, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $89.47 | Buy | Maintains | $89.47 | +22.65% | May 28, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $97.00 | Buy | Maintains | $97.00 | +32.97% | May 28, 2026 |
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $87.31 | Buy | Maintains | $87.31 | +19.68% | Apr 4, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $91.08 → $91.13 | Buy | Maintains | $91.08 → $91.13 | +24.92% | Mar 30, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $78.00 | Buy | Maintains | $78.00 | +6.92% | Mar 24, 2026 |